Tag: IDT Australia
IDT Australia receives grant to establish first commercial ADC manufacturing hub
IDT Australia Limited announced its successful bid for a Victoria State Government grant worth $3.8 million to support the creation of Australia’s inaugural cGMP Antibody-Drug-Conjugate (ADC) manufacturing facility.
IDT announces successful manufacture of Australia’s first mRNA COVID-19 vaccine candidate
It took just five months for Victorian scientists and manufacturers to develop Australia's first mRNA COVID-19 vaccine candidate — the country's first ever mRNA medicinal product – allowing...
IDT Australia ready to begin small-scale manufacturing of Australia’s first mRNA vaccine in preparation...
Boronia-based company IDT Australia is set to take delivery of a key piece of equipment that will enable the critical manufacturing capability of mRNA...
IDT in talks to manufacture Australia’s first COVID-19 vaccine candidate
Melbourne-based pharmaceutical manufacturer IDT Australia is locked in discussions with the Victorian Government, mRNA Victoria and the Monash Institute of Pharmaceutical Sciences (MIPS) to...
IDT secures medicinal cannabis manufacturing licence
Pharmaceutical manufacturing company IDT Australia has announced that it has been granted a Medicinal Cannabis Manufacturing Licence by the Department of Health - Office...
IDT Australia has filed an ANDA for Temozolomide approval
IDT Australia Limited (ASX:IDT) has filed an Abbreviated New Drug Application (ANDA) with the U.S Food and Drug Administration (FDA) for approval to market...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
